Beta
Back to CLS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CLS Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, total operating expenses for CLS reached approximately $101.8M USD, with SG&A Expenses at $71.2M USD and R&D Expenses at $30.7M USD, reflecting a notable increase in R&D spending compared to the prior quarter. Over the period from Q1'23 to Q4'25, R&D Expenses exhibited strong growth from $12.1M USD to $30.7M USD, with a particularly sharp acceleration in 2025 (peaking at $36.4M USD in Q3'25), indicating intensified investment in innovation. In contrast, SG&A Expenses showed volatility, declining from $77.9M USD in Q1'23 to a low of $56.9M USD in Q3'23 before surging to $112.5M USD in Q1'25 and stabilizing around $71.2M USD by year-end, suggesting fluctuating administrative efficiencies amid overall expense expansion in the stacked bar chart.